BIIB Biogen Inc

Biogen Inc is a biopharmaceutical company. It is engaged in discovering, developing, manufacturing and delivering therapies to patients for the treatment of neurological, rare and autoimmune diseases.

$271.10  +1.16 (0.43%)
As of 10/26/2021 15:59:57 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Large cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—General
Index country:  USA
Country of incorporation:  USA
IPO date:  02/08/2001
Outstanding shares:  146,892,712
Average volume:  982,222
Market cap:   $38,897,190,138
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    09062X103
ISIN:        US09062X1037
Sedol:      2455965
Valuation   (See tab for details)
PE ratio:   25.65
PB ratio:   3.74
PS ratio:   3.50
Return on equity:   14.21%
Net income %:   13.93%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy